Publikation

Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic stroke.

Wissenschaftlicher Artikel/Review - 21.12.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Honegger T, Schweizer J, Bicvic A, Westphal L, Schütz V, Inauen C, Pokorny T, Bracher K, Arnold M, Fischer U, Bonati L, De Marchis G, Nedeltchev K, Kahles T, Cereda C, Kägi G, Montaner J, Bustamante A, Palà E, Ntaios G, Foerch C, Luft A, Spanaus K, Saleh L, von Eckardstein A, Arnold M, Katan M. Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic stroke. Eur Stroke J 2022; 8:309-319.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Eur Stroke J 2022; 8
Veröffentlichungsdatum
21.12.2022
eISSN (Online)
2396-9881
Seiten
309-319
Kurzbeschreibung/Zielsetzung

Early identification of patients developing symptomatic intracranial hemorrhage and symptomatic brain edema after acute ischemic stroke is essential for clinical decision-making. Astroglial protein S-100B is a marker of blood-brain barrier disruption, which plays an important role in the formation of intracranial hemorrhage and brain edema. In this study, we assessed the prognostic value of serum S-100B for the development of these complications.